Drug intelligence / Profile preview

Fubishu

Development stage
Unknown
Lead developer
Zhejiang Kangde Pharmaceutical
Modality
Small Molecules
Administration
Vaginal
01

Overview

Fubishu is a traditional Chinese medicine (TCM) developed and manufactured by Zhejiang Kangde Pharmaceutical. It is formulated as an effervescent vaginal tablet specifically designed for the treatment of various gynecological inflammatory conditions. The medication is primarily indicated for vaginitis (including bacterial, trichomonal, and fungal/candidal types) and cervicitis, particularly when associated with symptoms such as abnormal vaginal discharge (leukorrhea), pruritus vulvae, and local redness or swelling. As a TCM formulation, it typically incorporates herbal extracts known for their antimicrobial, anti-inflammatory, and 'heat-clearing' properties. The effervescent dosage form allows for rapid disintegration and uniform distribution of the active ingredients within the vaginal cavity, providing localized therapeutic effects.

Brand names
Fubishu妇必舒
Other names
Fubishu Vaginal Effervescent Tablets妇必舒阴道泡腾片Fubishu Yindao Paoteng Pian

Beyond the preview

Go deeper on Fubishu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fubishu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call